Evidence map›Paper›PMID 34971477›Full record

ArticleMolecular genetics & genomic medicine2022

Neutrophil cytosolic factor 2 (NCF2) gene polymorphism is associated with juvenile-onset systemic lupus erythematosus, but probably not with other autoimmune rheumatic diseases in children.

Ivan Y Bakutenko, Irena D Haurylchyk, Natalia V Nikitchenko, Elena V Sechko, Inna A Kozyro, Alexei M Tchitchko, Galina M Batyan, Alexander V Sukalo, Nadezhda I Ryabokon

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ivan Y BakutenkoLaboratory of Molecular Basis of Genome Stability, Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Belarus.ORCID 0000-0002-4672-1124
Irena D HaurylchykLaboratory of Molecular Basis of Genome Stability, Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Belarus.
Natalia V NikitchenkoLaboratory of Molecular Basis of Genome Stability, Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Belarus.
Elena V Sechko1st Department of Childhood Diseases, Belarusian State Medical University, Minsk, Belarus.
Inna A Kozyro1st Department of Childhood Diseases, Belarusian State Medical University, Minsk, Belarus.
Alexei M Tchitchko1st Department of Childhood Diseases, Belarusian State Medical University, Minsk, Belarus.
Galina M Batyan1st Department of Childhood Diseases, Belarusian State Medical University, Minsk, Belarus.
Alexander V Sukalo1st Department of Childhood Diseases, Belarusian State Medical University, Minsk, Belarus.
Nadezhda I RyabokonLaboratory of Molecular Basis of Genome Stability, Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Belarus.ORCID 0000-0002-4820-9722
Belarusian State Medical University · BYInstitute of Genetics and Cytology of the National Academy of Sciences of Belarus · BY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGenetic variations of neutrophil cytosolic factor 2 (NCF2), a subunit of NADPH oxidase, are usually associated with chronic granulomatous disease, and their relationship with autoimmune disorders through the defective NADPH oxidase function during phagocytosis is suggested. Our study aimed to explore whether there is an association between the non-synonymous single nucleotide polymorphism in the NCF2 gene (rs17849502, NC_000001.11:g.183563445G>T) and the development of juvenile autoimmune rheumatic diseases.

methodsIn order to test this hypothesis, we conducted a pilot case-control study. In total, 709 children and adolescents, all Belarusians, were involved in the study including patients with juvenile-onset systemic lupus erythematosus (JSLE), juvenile idiopathic arthritis (JIA), Kawasaki disease (KD), and subjects without autoimmune and inflammatory diseases as the clinical control, as well as health newborns as the population control. Real-time polymerase chain reaction was used for genotyping.

resultsThe minor T allele of NCF2 occurred most frequently in patients with JSLE (OR = 2.60, 95% CI = 1.18-5.73, p = 0.023 as compared to the clinical control). In groups with JIA and KD, its frequency did not differ from the control. The TT genotype was only observed in 5.7% of patients with JSLE (p = 0.007), but not in other groups.

conclusionTherefore, our study suggested that NCF2 rs17849502 polymorphism is a potential genetic risk factor for JSLE, while it is probably not for such autoimmune rheumatic diseases as JIA or KD.

Indexed as

Lupus Erythematosus, SystemicNADPH OxidasesRheumatic DiseasesAdolescentCase-Control StudiesChildHumansInfant, NewbornPolymorphism, Single NucleotideNADPH OxidasesNCF2 protein, humangenetic risk factorjuvenile idiopathic arthritisjuvenile-onset systemic lupus erythematosusKawasaki diseaseNCF2 gene

Identifiers

PMID34971477
PMCPMC8801135
OpenAlexW4205167374

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.